Article
Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Document Type
Article
Publication Date
1-1-2022
Keywords
- washington,
- spokane,
- Diabetes Mellitus, Type 2,
- Humans,
- Pharmacists,
- Renal Insufficiency, Chronic,
- Sodium-Glucose Transporter 2 Inhibitors
Disciplines
Clinical Institute
Kidney & Diabetes
Department
Endocrinology
Department
Nephrology
Citation Information
Joshua J Neumiller, Jay H Shubrook, Tom Manley, Radica Alicic, et al.. "Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2022) Available at: http://works.bepress.com/katherine-tuttle/346/